Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/2347
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSambrook, P-
dc.contributor.authorGEUSENS, Piet-
dc.contributor.authorKeraudren, V-
dc.contributor.authorGaines, K-
dc.contributor.authorLeung, A-
dc.contributor.authorMelton, M-
dc.date.accessioned2007-11-13T16:21:22Z-
dc.date.available2007-11-13T16:21:22Z-
dc.date.issued2003-
dc.identifier.citationBONE, 32(5). p. S220-S221-
dc.identifier.issn8756-3282-
dc.identifier.urihttp://hdl.handle.net/1942/2347-
dc.language.isoen-
dc.publisherELSEVIER SCIENCE INC-
dc.titleEfficacy of Fosamax vs. evista comparison trial (effect-international): Results at 6 months-
dc.typeJournal Contribution-
dc.identifier.epageS221-
dc.identifier.issue5-
dc.identifier.spageS220-
dc.identifier.volume32-
local.format.pages2-
local.bibliographicCitation.jcatM-
dc.description.notesRoyal N Shore Hosp, Sydney, NSW, Australia. LUC, Biomed Res Inst, Diepenbeek, Belgium. Merck & Co Inc, Whitehouse Stn, NJ USA.-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.bibliographicCitation.oldjcatA5-
dc.identifier.isi000183123300641-
item.contributorSambrook, P-
item.contributorGEUSENS, Piet-
item.contributorKeraudren, V-
item.contributorGaines, K-
item.contributorLeung, A-
item.contributorMelton, M-
item.fulltextNo Fulltext-
item.accessRightsClosed Access-
item.fullcitationSambrook, P; GEUSENS, Piet; Keraudren, V; Gaines, K; Leung, A & Melton, M (2003) Efficacy of Fosamax vs. evista comparison trial (effect-international): Results at 6 months. In: BONE, 32(5). p. S220-S221.-
crisitem.journal.issn8756-3282-
crisitem.journal.eissn1873-2763-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.